Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Fenugreek Seed and Reduced Systolic Blood Pressure

Research synthesisModerate evidenceSmall effect3 studies · 2 beneficial · 1 neutral · 0 harmful

Across 3 studies, 2 reported small beneficial effects of fenugreek seed supplementation on reducing systolic blood pressure, with a meta-analysis (2023) showing a significant reduction (WMD: 3.46 mmHg). The third study found no significant between-group difference. Effects were typically observed at 12-14 weeks. The most-studied dose range is around 5-15 g/day of fenugreek seed.

  • Effective dose range: 5-15 g/day
  • Studied populations: individuals with type 2 diabetes and Alzheimer's disease; meta-analysis included general population

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. One study showed a within-group reduction but no significant between-group difference, indicating possible placebo effect or confounding. Doses and forms varied (whole seed vs. extract).

Generated Jun 13, 2026
Doses used in studies
  • g/day: 15 (median 15, IQR 1515) 2 studies
  • cc/day: 5 (median 5, IQR 55) 1 study
Time to effect
Median: 2.9 months · IQR 10.3 weeks3.5 months · Range 8 weeks4 months — Reported in 2 of 3 studies
3 of 3 papers
Back to top